Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02617277
Title Safety, Tolerability and Pharmacokinetics of AZD1775 Plus MEDI4736 in Patients With Advanced Solid Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca

Advanced Solid Tumor


Adavosertib + Durvalumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Denver Colorado 80218 United States Details
Research Site Sarasota Florida 34232 United States Details
Research Site Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from for the field